English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Background  Inflammation, metabolism, and epigenetic modulation are highly interconnected processes that can be altered during tumorigenesis. However, because of the complexity of these interactions, direct cause and effect during tumorigenesis have been difficult to prove. Previously, using a murine model of inflammation-induced colon tumorigenesis, we determined that the promoter of the catalytic subunit of DNA polymerase gamma ( Polg ) is DNA hypermethylated and silenced in inflammation-induced tumors, but not in non-inflammation-induced (mock) tumors, suggesting that inflammation can induce silencing of  Polg  through promoting DNA methylation during tumorigenesis.  Polg  is the only mitochondrial DNA polymerase and mutations in  Polg  cause mitochondrial diseases in humans. Because of the role of mitochondria in metabolism, we hypothesized that silencing of  Polg  in inflammation-induced tumors would result in these tumors having altered metabolism in comparison to mock tumors.    Methods  Inflammation-induced and mock colon tumors and colon epithelium from a mouse model of inflammation-induced colon tumorigenesis were assayed for alterations in  Polg  expression, mitochondria, and metabolism. Organoids derived from these tissues were used to study the direct effect of loss of  Polg  on mitochondria and metabolism.    Results  We demonstrate that inflammation-induced tumors with reduced  Polg  expression have decreased mitochondrial DNA content and numbers of mitochondria compared to normal epithelium or mock tumors. Tumoroids derived from mock and inflammation-induced tumors retained key characteristics of the original tumors. Inflammation-induced tumoroids had increased glucose uptake and lactate secretion relative to mock tumoroids. shRNA-mediated knockdown of  Polg  in mock tumoroids reduced mtDNA content, increased glucose uptake and lactate secretion, and made the tumoroids more resistant to oxidative stress.    Conclusions  These results suggest that inflammation-induced DNA methylation and silencing of  Polg  plays an important role in the tumorigenesis process by resulting in reduced mitochondria levels and altered metabolism. An enhanced understanding of how metabolism is altered in and drives inflammation-induced tumorigenesis will provide potential therapeutic targets.    Electronic supplementary material  The online version of this article (10.1186/s40170-018-0182-7) contains supplementary material, which is available to authorized users.

Inflammation-induced DNA methylation of DNA polymerase gamma alters the metabolic profile of colon tumors